The diagnostic use of recombinant human TSH (rhTSH) in follow-
up of differentiated thyroid cancer (DTC) is already approved,
however its application in 131I therapy is still to be evaluated.
We report results obtained in four patients with DTC
metastatic to central skeleton, in whom 5 courses of rtTSH aided
131I therapy were administered